Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs ropivacaine paravertebral block for postoperative psychological symptoms after thoracoscopic surgery
ChiCTR2500114947Phase 4Not yet recruiting
- Sponsor
- Qingdao Municipal Hospital
- Start
- Dec 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in anxiety disorder, postoperative depression, None and 2 more comparing Ropivacaine paravertebral nerve block with Liposomal bupivacaine paravertebral nerve block (2 arms). Primary endpoint: Postoperative psychological symptoms (anxiety, depression, stress, sleep). Planned start Dec 2025; status: not yet recruiting.
02
Drugs
bupivacaineropivacaine
03
Conditions
anxiety disorderpostoperative depressionsleep disorderpostoperative pain
Beyond the preview
Go deeper on ChiCTR2500114947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114947.